CoChat

Vaginal probiotics as therapeutic adjuncts for improving embryo transfer success rates: a systematic review and meta-analysis

Open access
Maleki-Hajiagha, Arezoo, Karimi, Rana, abbasi, Sheida, Emami, Neda, Amidi, Fardin · 2025 · BMC Pregnancy and Childbirth

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 24 of the 39 sources its claims cite were checked for support.

Abstract

BACKGROUND: Infertility treatments are continually evolving, with vaginal probiotic supplementation before embryo transfer (ET) being explored as a potential method to improve clinical outcomes. So, this systematic review evaluated the effect of vaginal probiotics on pregnancy rates following ET. METHODS: Studies were identified through PubMed, Scopus, Web of Science, Cochrane, and clinical trial registries up to October 17, 2024. We included prospective interventional studies (RCTs or quasi-experimental) focusing on pregnancy outcomes post-ET. We excluded non-prospective studies, non-vaginal routes of probiotic administration, and studies with insufficient methodological or statistical details. The data was extracted from each qualifying study by two reviewers and recorded using an electronic form. Results were synthesized using a random-effects model, with Mantel-Haenszel (MH) risk ratio (RR) and 95% confidence intervals (CI) calculated for ET outcomes. Also, subgroup analyses were done to explore the history of recurrent implantation failure (RIF) as a probable source of heterogeneity. RESULTS: We included six studies with 850 participants (419 in intervention and 431 in control groups). Vaginal probiotics showed a non-significant increase in clinical pregnancy rates compared to the control group (157 per 419 [37.47%] versus 136 per 431 [31.55%], respectively; RR: 1.19; P = 0.07), with similar findings in women with and without a history of RIF. No significant differences were found in biochemical pregnancy (RR: 1.04; P = 0.74) or ongoing pregnancy rates (RR: 1.09; P = 0.53). A non-significant reduction in miscarriage risk was observed (RR: 0.67; P = 0.12). CONCLUSIONS: Vaginal probiotics may offer a non-significant increase in clinical pregnancy rates and a slight non-significant reduction in miscarriage risk. However, considering the potential limitations of the included studies, findings should be interpreted with caution. Further research is needed to explore the potential of personalized probiotic therapy. PROSPERO REGISTRATION CODE: CRD42024550798.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found that vaginal probiotics before embryo transfer were associated with a non-significant increase in clinical pregnancy rates and a non-significant reduction in miscarriage risk. Across six studies (850 participants), the evidence was limited by small study numbers, variable probiotic regimens, and incomplete reporting.

Key findings

  • Six studies with 850 participants were included: 419 in the intervention group and 431 in the control group.
  • Clinical pregnancy was higher with vaginal probiotics but not statistically significant: 157/419 (37.47%) vs 136/431 (31.55%); RR 1.19, 95% CI 0.99 to 1.44; P = 0.07.
  • No significant differences were found for biochemical pregnancy (RR 1.04; 95% CI 0.84 to 1.28; P = 0.74) or ongoing pregnancy (RR 1.09; 95% CI 0.83 to 1.45; P = 0.53).
  • Miscarriage showed a non-significant reduction with probiotics: RR 0.67; 95% CI 0.40 to 1.12; P = 0.12.
  • Sensitivity analysis excluding three high-risk-of-bias studies still found no significant change in clinical pregnancy: RR 1.27; 95% CI 0.88 to 1.82; P = 0.20.

Methods

  • Systematic review and meta-analysis of prospective interventional studies (RCTs or quasi-experimental) evaluating vaginal probiotic supplementation before or during embryo transfer in infertile women.
  • Searched PubMed, Scopus, Web of Science, Cochrane, clinical trial registries, and grey literature sources up to October 17, 2024; six studies met inclusion criteria.
  • Synthesized outcomes with random-effects Mantel–Haenszel risk ratios and 95% confidence intervals; subgroup analyses explored recurrent implantation failure (RIF), and sensitivity analysis excluded non-randomized/quasi-experimental studies.

Limitations

  • The paper states that the included studies were few, and several key outcomes were underreported: implantation and live birth rates were insufficient for meta-analysis, and adverse pregnancy events were not reported.
  • The paper states that probiotic interventions varied in strains, doses, and duration, and participant infertility causes were diverse; these factors may affect consistency and applicability.
  • Evident from the text: most studies lacked placebo controls and some had high risk of bias or incomplete reporting, which could confound the observed effects.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12884-025-07338-0

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 PRISMA (preferred reporting items for systematic reviews and meta-analyses) 2020 flow diagram
Fig. 1 PRISMA (preferred reporting items for systematic reviews and meta-analyses) 2020 flow diagramCC BY-NC-ND · PubMed Central
Fig. 2 Risk of bias in randomized clinical trials according to ROB 2 Tool. a Methodological risk of bias summary: review authors' judgments about each methodological bias item for each included study; (b) Methodological risk of bias graph: review authors' judgments about each methodological bias item presented as percentages across all included studies
Fig. 2 Risk of bias in randomized clinical trials according to ROB 2 Tool. a Methodological risk of bias summary: review authors' judgments about each methodological bias item for each included study; (b) Methodological risk of bias graph: review authors' judgments about each methodological bias item presented as percentages across all included studiesCC BY-NC-ND · PubMed Central
Fig. 3 Comparison of clinical pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for clinical pregnancy rate. b Chi-square-based Q statistic and I2 value for heterogeneity assessment
Fig. 3 Comparison of clinical pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for clinical pregnancy rate. b Chi-square-based Q statistic and I2 value for heterogeneity assessmentCC BY-NC-ND · PubMed Central
Fig. 4 Assessment of publication bias in clinical pregnancy rates. This funnel plot visualizes potential publication bias in studies measuring clinical pregnancy rates. The Y-axis indicates the precision of each study, while the X-axis shows the effect size. The plot's foundation lies in the principle that larger studies provide more precise estimates of the true treatment effect. Studies included in the analysis are marked with blank (white) dots. A black-filled dot represents a hypothetical 'missing' study inferred through trim-and-fill analysis. The asymmetry of the funnel plot hints at possible publication bias, suggesting that the reported effect size of vaginal probiotics on clinical pregnancy rates might be inflated. Without this bias, the observed effect (white diamond) would likely gravitate towards a diminished or nonexistent impact (black diamond)
Fig. 4 Assessment of publication bias in clinical pregnancy rates. This funnel plot visualizes potential publication bias in studies measuring clinical pregnancy rates. The Y-axis indicates the precision of each study, while the X-axis shows the effect size. The plot's foundation lies in the principle that larger studies provide more precise estimates of the true treatment effect. Studies included in the analysis are marked with blank (white) dots. A black-filled dot represents a hypothetical 'missing' study inferred through trim-and-fill analysis. The asymmetry of the funnel plot hints at possible publication bias, suggesting that the reported effect size of vaginal probiotics on clinical pregnancy rates might be inflated. Without this bias, the observed effect (white diamond) would likely gravitate towards a diminished or nonexistent impact (black diamond)CC BY-NC-ND · PubMed Central
Fig. 5 Subgroup analysis of clinical pregnancy rate considering history of RIF.Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for clinical pregnancy rate in the RIF and non-RIF subgroups for probiotic and control groups. RIF: Recurrent Implantation Failure
Fig. 5 Subgroup analysis of clinical pregnancy rate considering history of RIF.Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for clinical pregnancy rate in the RIF and non-RIF subgroups for probiotic and control groups. RIF: Recurrent Implantation FailureCC BY-NC-ND · PubMed Central
Fig. 6 Comparison of biochemical pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for biochemical pregnancy rate (determined by BhCG detection in blood or urine). b Chi-square-based Q statistic and I2 value for heterogeneity assessment
Fig. 6 Comparison of biochemical pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for biochemical pregnancy rate (determined by BhCG detection in blood or urine). b Chi-square-based Q statistic and I2 value for heterogeneity assessmentCC BY-NC-ND · PubMed Central
Fig. 7 Comparison of ongoing pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for ongoing pregnancy rates. b Chi-square-based Q statistic and I2 value for heterogeneity assessment
Fig. 7 Comparison of ongoing pregnancy rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for ongoing pregnancy rates. b Chi-square-based Q statistic and I2 value for heterogeneity assessmentCC BY-NC-ND · PubMed Central
Fig. 8 Comparison of miscarriage rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for miscarriage rate. b Chi-square-based Q statistic and I2 value for heterogeneity assessment
Fig. 8 Comparison of miscarriage rate between probiotics and control groups. a Forest plot detailed Mantel–Haenszel risk ratio and 95% confidence intervals for miscarriage rate. b Chi-square-based Q statistic and I2 value for heterogeneity assessmentCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

16 Valid · 1 Not valid · 9 Not checked · 54 Own results and interpretations

34 more claims

Create a free account to see all 80 claims and to verify the 3 references still open.

See all claims — free account
  • It may state two separate claims as one. 28
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Consistentz = 1.82reported p = .07 · recomputed p = .069

    “(Z = 1.82, p = .07”

  • Consistentz = 1.28reported p = .2 · recomputed p = .201

    “(Z = 1.28, p = .20”

  • Consistentz = 0.33reported p = .74 · recomputed p = .741

    “(Z = 0.33, p = .74”

  • Consistentz = 0.63reported p = .53 · recomputed p = .529

    “(Z = 0.63, p = .53”

  • Consistentz = -1.54reported p = .12 · recomputed p = .124

    “(Z = −1.54, p = .12”

5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. Pengying X, Microecology YX-CJ of, 2023 undefined. The application of lactobacillus vaginal capsule adjuvant therapy in patients with repeated implantation failure of ART. Chinese J Microecology. 2023;35:817–20. https://doi.org/10.13381/j.cnki.cjm.202307013. · doi:10.13381/j.cnki.cjm.202307013

Cited by

See all 13

Metadata

Authors
Maleki-Hajiagha, A., Karimi, R., abbasi, S., Emami, N., & Amidi, F.
Affiliations
Tehran University of Medical Sciences (IR)
Corresponding author
Amidi, Fardin
Venue
BMC Pregnancy and Childbirth
Published
2025-03-08
Volume
25
Issue
1
Pages
262-262
ISSN
1471-2393 (ISSN-L)
OpenAlex
W4408247047
Cited by
13
References
45
Citations by year
2026: 9 · 2025: 4
FWCI
1.43
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Pregnancy and Childbirth (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
vaginal probiotics, embryo transfer, clinical pregnancy rate, recurrent implantation failure, biochemical pregnancy, miscarriage, infertility treatment, probiotic supplementation
MeSH terms
Administration, Intravaginal, Embryo Transfer, Female, Humans, Pregnancy, Pregnancy Outcome, Vagina, Pregnancy Rate, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vaginal probiotics as therapeutic adjuncts for improving embryo transfer success rates: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12884-025-07338-0
The paper
Maleki-Hajiagha, A., Karimi, R., abbasi, S., Emami, N., & Amidi, F. (2025). Vaginal probiotics as therapeutic adjuncts for improving embryo transfer success rates: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-025-07338-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.